April 2, 2019 / 11:14 AM / 17 days ago

BRIEF-Allergan And Molecular Partners Announce Topline Safety Results From Maple Study Of Abicipar Pegol

April 2 (Reuters) - Allergan plc:

* ALLERGAN AND MOLECULAR PARTNERS ANNOUNCE TOPLINE SAFETY RESULTS FROM MAPLE STUDY OF ABICIPAR PEGOL

* MOLECULAR PARTNERS AG - ABICIPAR BLA SUBMISSION TO FDA PLANNED FOR FIRST HALF OF 2019

* MOLECULAR PARTNERS - MAPLE STUDY USED A MODIFIED MANUFACTURING PROCESS AND DEMONSTRATED DECREASED INTRAOCULAR INFLAMMATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below